Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-24-000956
Filing Date
2024-11-14
Accepted
2024-11-14 12:04:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 oruka13ga1-11142024.htm SC 13G/A 139525
  Complete submission text file 0001013594-24-000956.txt   141457
Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-51477 | Film No.: 241459161
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address ONE STAMFORD PLAZA 263 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address ONE STAMFORD PLAZA 263 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-880-1802
Allostery Investments LP (Filed by) CIK: 0001978599 (see all company filings)

EIN.: 883328512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A